Cas:16672-87-0 Ethephon manufacturer & supplier

We serve Chemical Name:Ethephon CAS:16672-87-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethephon

Chemical Name:Ethephon
CAS.NO:16672-87-0
Synonyms:2-Chloroethylphosphonic acid,Ethephon;g996;(2-Chloroethyl)phosphonic acid;Ethel;cepha;2-chloroethylphosphonic acid;(2-chloroethyl)-phosphonic acid;Arvest;PLUCK;Prep;CEPA;2-chloroethyl-phoshonic acid;CEP;Ethefon;MFCD00002142;gagro;2-Chloroethanephosphonic acid;2-cepa;Phosphonic acid, (2-chloroethyl)-;EINECS 240-718-3;Ethephon
Molecular Formula:C2H6ClO3P
Molecular Weight:144.494
HS Code:2931900043

Physical and Chemical Properties:
Melting point:70-72 °C(lit.)
Boiling point:333.4±44.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.479
PSA:67.34000
Exact Mass:143.974304
LogP:-1.42

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2928 6.1/PG 2
Packing Group:II


Contact us for information like 2-Chloroethylphosphonic acid,Ethephon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethephon physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00002142 Use and application,2-chloroethyl-phoshonic acid technical grade,usp/ep/jp grade.


Related News: During an investor event last month, Walmsley laid out her blueprint for the new GSK. It features a 5% average sales growth rate in the next five years, leading to total sales of £33 billion ($46 billion) by 2031. (5-methyl-2-propan-2-ylphenyl) acetate manufacturers The collaborative research and exclusive license agreement inked in December didn’t have a price tag, but the two companies revealed the eye-popping figure Tuesday that includes an undisclosed upfront payment to PeptiDream and other cash drops subject to certain clinical milestones. (±)-1,2:5,6-di-O-isopropylidene-myo-inositol suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. Azithromycin B vendor & factory.